First Iraqi case of OTUD6B-related disorder: A novel splice-site variant and review of the literature
Keywords:
OTUD6B-related disorder, splice-site variant, intellectual disability, consanguinity, rare disease, whole-exome sequencingAbstract
OTUD6B-related disorder is a rare autosomal recessive syndrome characterized by intellectual disability, developmental delay, seizures, and dysmorphic features. Since its first description in 2017, fewer than 25 cases have been reported globally. Here, we describe the first genetically confirmed case from Iraq with a novel homozygous splice-site variant in the OTUD6B gene.
Whole-exome sequencing (WES) was performed on a 2.5-year-old male presenting with global developmental delay, infantile spasms, microcephaly, dysmorphic facial features, and a ventricular septal defect. Both parents were first cousins. WES identified a novel homozygous splice-site variant in OTUD6B: c.235-3C>G. This variant was absent in gnomAD and 1000 Genomes databases and is predicted to disrupt normal mRNA splicing. The same variant was found in a heterozygous state in both parents. Clinically, the patient shares many hallmark features of OTUD6B-related disorder, including hypotonia, feeding difficulties, ear anomalies, and abnormal dentition. Additional findings in this case include a prominent cartilaginous coccyx, metopic suture craniosynostosis, and reduced visual and auditory acuity, expanding the known phenotypic spectrum. This case confirms the pathogenicity of a novel splice-site variant in OTUD6B and further illustrates the phenotypic variability of OTUD6B-related disorder. It emphasizes the diagnostic value of WES in consanguineous populations and contributes new data to the global understanding of this rare condition.
References
1. Santiago-Sim T, Burrage LC, Ebstein F, et al. Biallelic variants in OTUD6B cause an intellectual disability syndrome associated with seizures and dysmorphic features. Am J Hum Genet. 2017;100(4):676-88. doi:10.1016/j.ajhg.2017.03.001
2. Romero-Ibarguengoitia ME, Cantú-Reyna C, Gutierrez-González D, Sanz Sánchez MA, et al. Comparison of genetic variants and manifestations of OTUD6B-related disorder: the first Mexican case. J Investig Med High Impact Case Rep. 2020;8:2324709620957777. doi:10.1177/2324709620957777
3. Abdel-Salam GMH, Abdel-Hamid MS, Sayed ISM, Zechner U, Bolz HJ. OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype. J Hum Genet. 2022;67(1):55-64. doi:10.1038/s10038-021-00966-2
4. Straniero L, Rimoldi V, Soldà G, et al. First replication of the involvement of OTUD6B in intellectual disability syndrome with seizures and dysmorphic features. Front Genet. 2018;9:464. doi:10.3389/fgene.2018.00464
5. Alkuraya FS. Phenotypic expansion of OTUD6B-related syndrome. Am J Med Genet A. 2020;182(6):1530-1. doi:10.1002/ajmg.a.61548
6. Sánchez-Soler MJ, Serrano-Antón AT, López-González V, Ballesta Martínez MJ, Guillén-Navarro E. Primer caso español de discapacidad intelectual sindrómica con dismorfia facial, crisis y anomalías de extremidades por mutaciones bialélicas en el gen OTUD6B. An Pediatr (Engl Ed). 2020;92(3):169-71. [Spanish]. doi:10.1016/j.anpedi.2019.03.010
7. Hanna J, Hathaway NA, Tone Y, et al. Deubiquitinating enzyme Ubp6 functions noncatalytically to delay proteasomal degradation. Cell. 2006;127(1):99-111. doi:10.1016/j.cell.2006.07.038
8. Bustos F, Segarra-Fas A, Chaugule VK, et al. RNF12 X-linked intellectual disability mutations disrupt E3 ligase activity and neural differentiation. Cell Rep. 2018;23(6):1599-611. doi:10.1016/j.celrep.2018.04.022
9. Xu Z, Zheng Y, Zhu Y, Kong X, Hu L. Evidence for OTUD-6B participation in B lymphocytes cell cycle after cytokine stimulation. PLoS One. 2011;6(1):e14514. doi:10.1371/journal.pone.0014514
10. The Human Protein Atlas. Tissue expression of OTUD6B - Summary - The Human Protein Atlas. Accessed: August 2025.
11. Sobol A, Askonas C, Alani S, et al. Deubiquitinase OTUD6B isoforms are important regulators of growth and proliferation. Mol Cancer Res. 2017;15(2):117-27. doi:10.1158/1541-7786.MCR-16-0281-T
12. LiCausi F, Hartman NW. Role of mTOR complexes in neurogenesis. Int J Mol Sci. 2018;19(5):1544. doi:10.3390/ijms19051544
13. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405-24. doi:10.1038/gim.2015.30
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Dalya Saidi, Marya Obeidat
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
